Phase I trial HMR code: 23-006
This is a Phase 1 clinical trial designed to test a new medicine in healthy volunteers. Phase 1 studies are the very first step in testing potential treatments in humans. Their main purpose is to make sure the medicine is safe, work out the best dose, and see how it travels through the body. At this stage, specific scientific details about the medicine are kept private by the study organizers. This is standard practice in the UK for early research to protect intellectual property. Full details will be shared publicly within 30 months after the trial finishes. Taking part helps scientists understand whether a medicine is safe enough to be tested in patients with specific illnesses later on. If you join, you will receive thorough medical check-ups and close care from healthcare professionals throughout your time on the study.
At a glance
What is this study about?
Before any new medicine can be prescribed on the NHS, it must go through careful testing to prove it is safe. Phase 1 trials are the first time a new treatment is given to human volunteers. In these early trials, researchers want to see what happens to the medicine inside the body, how quickly it leaves the system, and whether it causes any unwanted side effects.
You might notice that the exact name of the medicine and the illness it aims to treat are not listed here. In the UK, research rules allow companies to keep certain commercial details private during early testing. However, the trial must still follow strict UK safety regulations and be approved by an independent research ethics committee before any volunteer can take part. Full scientific details will be published within 30 months of the study ending.
Healthy volunteers play a crucial role in modern medicine. By testing a drug in people without medical conditions, doctors can clearly see its direct effects. The information gathered from this study will help doctors decide if the treatment is promising and safe enough to move forward to larger trials in patients who need it.
Key takeaways
- This is a Phase 1 trial testing the safety of a new medicine in healthy volunteers.
- Full details about the drug are temporarily private under UK rules, but will be published within 30 months after the study ends.
- The study has been reviewed and approved by an independent UK research ethics committee.
- Doctors and nurses will closely supervise your health during all visits and tests.
- Participation is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
This trial is looking for healthy volunteers. In general, this means people who do not have major ongoing medical conditions and who are not taking regular prescription medicines that could interfere with the study results.
The official listing notes that people of all ages and sexes may be considered. However, the research clinic will have specific rules about who can safely take part. They will ask you detailed questions about your general health, lifestyle, and medical background before deciding if the trial is right for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You consider yourself to be in good overall health.
- You do not have serious or uncontrolled long-term health conditions.
- You are willing to undergo health checks, including blood tests and heart tracings.
- You are able to travel to the clinic and attend all scheduled visits or overnight stays.
- You are not currently taking part in another clinical drug trial.
What does participation involve?
Taking part usually begins with a screening appointment at the clinic. During this visit, medical staff will check your health with tests such as blood tests, urine samples, and a heart tracing (ECG). If you are accepted, you will be given the study medicine. You may need to stay at the clinic for one or more nights or return for several daytime visits so nurses and doctors can check your blood pressure, take blood samples, and watch for any side effects. After the treatment phase ends, you will have follow-up visits to ensure you remain fully well. The research team will explain the exact schedule and duration before you agree to take part.
Potential risks and benefits
Locations (1)
- HMRApproximateLondon, England
Common questions
Why are full details about this study kept private?
UK regulations allow companies to protect commercial secrets during very early testing. However, the trial has still passed rigorous safety and ethical reviews, and full details will be published later.
Will I be paid for taking part?
Most Phase 1 trials offer healthy volunteers financial compensation for their time, travel expenses, and any inconvenience caused.
What is the purpose of a Phase 1 trial?
Phase 1 trials check how safe a new medicine is in humans, help find the right dosage, and look at how the body breaks it down.
Is taking part in this trial safe?
Every clinical trial carries some risk because the medicine is new. However, your health will be monitored continuously by experienced doctors and nurses who can treat any issues immediately.
Can I leave the study if I change my mind?
Yes. Joining a clinical trial is always voluntary. You can stop participating at any point, and your normal healthcare will not be affected.
How to find out more
Balázs Lázár
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.